✦ LIBER ✦

Growth Hormone Injections Improve Bone Quality in a Mouse Model of Osteogenesis Imperfecta

✍ Scribed by Donna King; David Jarjoura; Heather A McEwen; Michael J Askew

Book ID: 111485244
Publisher: American Society for Bone and Mineral Research
Year: 2005
Tongue: English
Weight: 107 KB
Volume: 20
Category: Article
ISSN: 0884-0431
DOI: 10.1359/jbmr.050108

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sclerostin antibody improves skeletal pa

Sclerostin antibody improves skeletal parameters in a Brtl/+ mouse model of osteogenesis imperfecta

✍ Sinder, Benjamin P; Eddy, Mary M; Ominsky, Michael S; Caird, Michelle S; Marini, 📂 Article 📅 2012 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 766 KB

Brittle IV Mouse Model for Osteogenesis

Brittle IV Mouse Model for Osteogenesis Imperfecta IV Demonstrates Postpubertal Adaptations to Improve Whole Bone Strength

✍ Kenneth M Kozloff; Angela Carden; Clemens Bergwitz; Antonella Forlino; Thomas E 📂 Article 📅 2004 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 331 KB

Alendronate affects long bone length and

Alendronate affects long bone length and growth plate morphology in the oim mouse model for Osteogenesis Imperfecta

✍ K.D Evans; S.T Lau; A.M Oberbauer; R.B Martin 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Use of marrow stromal cells to replace b

Use of marrow stromal cells to replace bone cells in a transgenic mouse model for osteogenesis imperfecta

✍ Ruth F. Pereira; Kenneth W. Halford; Michael D. O'Hara; Marea D. Polland; Patric 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 97 KB

The effects of RANKL inhibition on fract

The effects of RANKL inhibition on fracture healing and bone strength in a mouse model of osteogenesis imperfecta

✍ Demetris Delos; Xu Yang; Benjamin F. Ricciardi; Elizabeth R. Myers; Mathias P.G. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 387 KB 👁 1 views

## Abstract Currently, the standard treatment for osteogenesis imperfecta (OI) is bisphosphonate therapy. Recent studies, however, have shown delayed healing of osteotomies in a subset of OI patients treated with such agents. The current study sought to determine the effects of another therapy, RAN

Replacement of bone cells expressing a m

Replacement of bone cells expressing a muated COL1A1 gene in a transgenic mouse for osteogenesis imperfecta

✍ R.F. Percira; K.W. Halford; M.D. O'hara; M.D. Pollard; A.V. Laptev; D.J. Prockop 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 91 KB